Stock Events

Stock Events

Abbott Laboratories 

$110.37
4505
-$0.88-0.79% 20:02 Today
+$0.28+0.25%20:07After hours

Statistics

Day High
111.41
Day Low
109.35
52W High
137.49
52W Low
81.97
Volume
7,202,437
Avg. Volume
12,061,582
Mkt Cap
190.98B
P/E Ratio
26.31
Dividend Yield
2.27%
Dividend
2.5

Upcoming

Dividends

2.27%Dividend Yield
Aug 26
$0.63
May 26
$0.63
Feb 26
$0.63
Nov 25
$0.59
Aug 25
$0.59
10Y Growth
9.33%
5Y Growth
8.54%
3Y Growth
7.57%
1Y Growth
7.02%

Earnings

21OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
1.07
1.21
1.36
1.5
Expected EPS
1.419031
Actual EPS
N/A

Financials

14.72%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
44.33BRevenue
6.52BNet Income

Analyst Ratings

122.12Average Price Target
The highest estimate is 143.00.
From 17 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ABT. It's not an investment recommendation.
Apple
1089
AAPL
Microsoft
1087
MSFT
Johnson & Johnson
923
JNJ
Coca-Cola
920
KO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson competes with Abbott in multiple segments including medical devices, diagnostics, and pharmaceuticals, making it a direct competitor across several of Abbott's business lines.
Medtronic
MDT
Mkt Cap116.83B
Medtronic competes with Abbott in the medical devices sector, particularly in cardiovascular and diabetes care products.
Thermo Fisher Scientific
TMO
Mkt Cap217.52B
Thermo Fisher Scientific competes with Abbott in the diagnostics and life sciences sector, offering a range of analytical instruments, reagents, and consumables.
Danaher
DHR
Mkt Cap142.32B
Danaher Corporation competes with Abbott in the diagnostics and life sciences industry, particularly through its subsidiary Cepheid, which offers molecular diagnostics solutions.
Boston Scientific
BSX
Mkt Cap75.11B
Boston Scientific competes with Abbott in the medical devices sector, especially in cardiovascular products.
Baxter International
BAX
Mkt Cap13.82B
Baxter International competes with Abbott in the medical devices and nutrition sectors, offering products for critical care, nutrition, renal care, and more.
Stryker
SYK
Mkt Cap130.11B
Stryker competes with Abbott in the medical devices sector, particularly in orthopedics, which indirectly competes with Abbott's offerings in other medical device categories.
Becton Dickinson
BDX
Mkt Cap49.96B
Becton, Dickinson and Company competes with Abbott in the medical technology sector, offering devices, laboratory equipment, and diagnostic products.
Resmed
RMD
Mkt Cap32.38B
ResMed competes with Abbott in the health sector by providing medical devices for sleep disorders and respiratory conditions, which complements Abbott's broader medical device portfolio.

About

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Show more...
CEO
Robert Ford
Employees
115000
Country
United States
ISIN
US0028241000
WKN
000850103

Listings

XETRA
DE
ABL.XETRA
MI
IT
1ABT.MI
F
DE
ABL0.F
ST
SE
ABTO.ST

0 Comments

Share your thoughts

FAQ

What is Abbott Laboratories stock price today?▼
The current price of ABT is $110.37 USD — it has decreased by -0.79% in the past 24 hours. Watch Abbott Laboratories stock price performance more closely on the chart.
What is Abbott Laboratories stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Abbott Laboratories stocks are traded under the ticker ABT.
Is Abbott Laboratories stock price growing?▼
ABT stock has risen by +1.65% compared to the previous week, the month change is a +9.66% rise, over the last year Abbott Laboratories has showed a -16.2% decrease.
What is Abbott Laboratories market cap?▼
Today Abbott Laboratories has the market capitalization of 190.98B
When is the next Abbott Laboratories earnings date?▼
Abbott Laboratories is going to release the next earnings report on October 21, 2026.
What were Abbott Laboratories earnings last quarter?▼
ABT earnings for the last quarter are 1.31 USD per share, whereas the estimation was 1.28 USD resulting in a +2.56% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Abbott Laboratories revenue for the last year?▼
Abbott Laboratories revenue for the last year amounts to 44.33B USD.
What is Abbott Laboratories net income for the last year?▼
ABT net income for the last year is 6.52B USD.
Does Abbott Laboratories pay dividends?▼
Yes, ABT dividends are paid quarterly. The last dividend per share was 0.63 USD. As of today, Dividend Yield (FWD)% is 2.27%.
How many employees does Abbott Laboratories have?▼
As of August 17, 2026, the company has 115,000 employees.
In which sector is Abbott Laboratories located?▼
Abbott Laboratories operates in the Health & Wellness sector.
When did Abbott Laboratories complete a stock split?▼
The last stock split for Abbott Laboratories was on June 01, 1998 with a ratio of 2:1.
Where is Abbott Laboratories headquartered?▼
Abbott Laboratories is headquartered in ABBOTT PARK, United States.